were collected 15 and 5 minutes be-fore study drug administration, then10, 20, 30, 45, 60, 90, 120, and 150minutes and 3, 4, 5, 6, 7, 8, 9, 10, 11,12, and 15 hours after administra-tion. Samples for plasma glucose andinsulin measurements were collected15 and 5 minutes before study drugadministration, then 10, 20, 30, 45,60, 90, 120, and 150 minutes and 3, 4,5, 6, 7, and 8 hours after administra-tion. Samples for plasma glucagonmeasurements were collected 15 and5 minutes before study drug admin-istration, then 10, 20, 30, 45, 60,90, 120, 150, and 180 minutes afteradministration. Study B . This randomized, single- blind, placebo-controlled study con-sisted of two parts. OAA treatmentwas stopped for 14 days before studyday 1 and for the duration of thestudy. In part 1, six patients wererandomized to one of three treat-ment sequences to receive a singles.c. dose of exenatide (0.01 or 0.1  Âµg/ kg) or placebo on three consecutive